Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Hmm! Hate to see this for people! Also will the price suffer? ( that’s secondary to the people question )

$bluebird bio (BLUE.US)$ FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)
Benzinga· 23 mins ago
WARNING: HEMATOLOGIC MALIGNANCY Hematologic malignancy, including life-threatening cases of myelodysplastic syndrome, has occurred in patients treated with SKYSONA. Patients have been diagnosed between 14 months and 7.5 years after SKYSONA administration, and the cancers appear to be the result of the SKYSONA lentiviral vector, Lenti-D, integration in proto-oncogenes. Monitor patients closely for evidence of malignancy through complete blood counts at least every 6 months and through assessments for evidence for clonal expansion or predominance at least twice in the first year and annually thereafter; consider bone marrow evaluations as clinically indicated [see Warnings and Precautions (5.1)].
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
19
Translate
Report
4029 Views
Comment
Sign in to post a comment

View more comments...

3651Followers
23Following
54KVisitors
Follow